Andrew Snow

14PUBLICATIONS
167CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Cancer therapy (excl. chemotherapy and radiation therapy)Innate immunityPredictive and prognostic markersInfant and child health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jun 12, 2026
Deleterious germline CARD11 gain-of-function variants alter human B-cell and CD4+ T-cell differentiation and function.

|Feb 26, 2026
PD-1 protects expanding human T cells from premature restimulation-induced cell death by modulating TCR and CD28 signaling.

Katherine P Lee, Sara Elster, Benjamin Epstein

|Mar 20, 2025
Dominant interfering CARD11 variants disrupt JNK signaling to promote GATA3 expression in T cells.

Bradly M Bauman, Jeffrey R Stinson, Melissa A Kallarakal

|Oct 03, 2024
A20 intrinsically influences human effector T-cell survival and function by regulating both NF-κB and JNK signaling.

Gina Dabbah-Krancher, Allison Ruchinskas, Melissa A Kallarakal

|Jan 18, 2023
Mistuned NF-κB signaling in lymphocytes: lessons from relevant inborn errors of immunity.

Gina Dabbah-Krancher, Andrew L Snow

|May 16, 2022
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies.

Jérémy Manry, Paul Bastard, Adrian Gervais

Pageof 3

Frequent Collaborators

4 joint publications

Bradly M Bauman

3 joint publications

Clifton L Dalgard

3 joint publications

Aurélie Cobat

3 joint publications

Paolo Bonfanti